Connection

David Amrol to Cross-Over Studies

This is a "connection" page, showing publications David Amrol has written about Cross-Over Studies.
Connection Strength

0.059
  1. Soluble CD23 and interleukin-1 receptor antagonist in human asthmatics following antigen challenge. J Asthma. 2005 Feb; 42(1):73-6.
    View in: PubMed
    Score: 0.059
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.